ClinicalTrials.gg
RecruitingNCT07296003Updated Nov 5, 2026

Motor Development and Early Predictors of Psychomotor Outcomes in Preterm and Term Infants Assessed by MOS-R and Caregiver Questionnaire at 18 and 36 Months

An observational study in Neurodevelopmental Disorders, Motor Skills Disorders and Infant, Premature Development, sponsored by Masaryk University. Recruiting at 3 sites in Czechia. Open to participants aged Up to 3 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-05.

Primary conditionMotor Skills DisordersRegistry: Neurodevelopmental DisordersReclassifiedWhy we changed it
Registry
Neurodevelopmental Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Motor Skills Disorders
Why
  1. The study's listed conditions name Motor Skills Disorders, a narrower term within Neurodevelopmental Disorders.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Masaryk University · Observational

How we know

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 7 months later.
Updated Nov 5, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
60
Ages
Up to 3 Years
Sex
All
01

Study summary

This study examines how early motor behavior in infants relates to their later psychomotor development. Researchers will observe both preterm and full-term infants during the first months of life, using video-based assessments to evaluate spontaneous movements and early postural control. These early motor patterns will be scored with the Motor Optimality Score - Revised (MOS-R).

When the children reach 18 and 36 months of age, their development in areas such as motor skills, communication, sensory processing, and social behavior will be evaluated through a caregiver-completed questionnaire.

The purpose of the study is to determine whether early motor quality can predict later developmental outcomes, whether preterm and full-term infants with similar motor scores develop differently, and whether early therapy may improve outcomes for infants with low MOS-R results.

Read the detailed description

This study uses a combined retrospective-prospective observational design. The retrospective component includes previously recorded video assessments of spontaneous motor behavior and postural control collected during routine clinical examinations in both preterm infants and a comparison group of full-term infants. These recordings were originally obtained as part of standard care in the neonatal unit and physiotherapy outpatient clinic and were subsequently anonymized for research purposes. Early motor quality was evaluated using standardized scoring procedures, including the Motor Optimality Score - Revised (MOS-R) and detailed general movement assessment.

The prospective component is used to complete developmental follow-up. Caregivers are contacted when the child reaches 18 and 36 months of age and are asked to complete a validated questionnaire assessing domains such as motor development, communication, sensory processing, and socio-emotional functioning. By integrating retrospective motor assessments with prospective developmental outcomes, the study enables a rigorous analysis of the predictive relationship between early motor patterns and later psychomotor development.

A combined design is necessary because high-quality video recordings of early motor behavior cannot be reproduced once the infant has aged, and the early spontaneous movement repertoire represents a unique neurodevelopmental window. The retrospective use of existing recordings reduces participant burden and allows comparison between preterm infants and full-term infants who underwent the same standardized motor assessment. The prospective follow-up ensures that developmental outcomes are measured consistently and with sufficient temporal precision. Overall, this design increases feasibility, minimizes risk, and provides a robust framework for evaluating early markers of developmental trajectories.

02

Conditions studied

  • Neurodevelopmental Disorders
  • Motor Skills Disorders
  • Infant, Premature Development
  • Infant, Term Development
  • Postural Balance

Browse trials for

Keywords

  • General Movements Assessment
  • Motor Optimality Score Revised
  • Postural Control
  • Full-Term Infants
  • Preterm Infants
  • Neurodevelopmental Outcomes
03

In context

Motor Skills Disorders Reclassified

105 studies on the registry are indexed under Motor Skills Disorders; 29 are open to participants now.

This study's planned enrollment of 60 is below the median of 92 across 28 observational studies indexed under Motor Skills Disorders.

Browse Motor Skills Disorders studies →

Lead sponsor

Masaryk University is the lead sponsor of 47 studies on the registry; 20 are open to participants now.

Compared within Motor Skills Disorders, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Neurodevelopmental Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
Up to 3 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants in this study are infants who were seen for routine clinical follow-up in the Neonatal Unit and the physiotherapy outpatient clinic at Pardubice Regional Hospital and cooperating rehabilitation centers. During their early visits, these infants had video recordings made of their spontaneous movements as part of standard clinical care. Both preterm and full-term infants are included. When the children reach approximately 18-36 months of age, their parents or legal guardians are invited to complete a developmental questionnaire as part of the study's follow-up.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The child was born either preterm or full-term. Both groups are included in the study.
  • The child completed a video recording of early movements during routine check-ups in the first months of life.
  • The parents or legal guardians agree to participate and give .
  • The child will be available for follow-up at around 18-36 months of age, when parents will complete a developmental questionnaire.

Exclusion criteria

Exclusion Criteria:

  • There is no usable video recording of the child's early spontaneous movements from the neonatal or early infant period.
  • The child has a diagnosed medical condition that makes movement assessment impossible (for example, severe congenital anomalies or conditions preventing typical movement).
  • Parents do not wish to participate or withdraw their consent.
  • The child is not available for follow-up, meaning that the developmental questionnaire at 18-36 months cannot be completed.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
60 participants (estimated)
Target follow-up
3 Years
Patient registry
Yes

Groups and cohorts

  • Preterm Infants Cohort

    Infants born moderately or late preterm (32-36 weeks gestation) who completed standardized video-based assessment of early spontaneous movements in infancy. Within this cohort, infants will be further stratified according to the quality of early spontaneous movements as evaluated by the Motor Optimality Score - Revised (MOS-R), distinguishing between typical movement quality and reduced or atypical movement quality. Among infants showing reduced or atypical movement quality, naturally occurring differences in early physiotherapy exposure will also be described. These characteristics serve as analytic stratification factors and do not define additional study groups.

    Other: Vojta method

  • Full-Term Infants

    Infants born at or after 37 weeks of gestation who completed the same standardized early assessment of spontaneous movements. As in the preterm cohort, infants will be stratified based on the quality of early spontaneous movements assessed using the Motor Optimality Score - Revised (MOS-R), distinguishing between typical and reduced or atypical movement quality. For infants with reduced/atypical movement quality, differences in early physiotherapy exposure may also be explored. These variables function as stratification factors for analysis and are not defined as separate study cohorts.

    Other: Vojta method

Interventions

  • OtherVojta method

    Vojta method, also known as reflex locomotion, was offered to infants who demonstrated atypical or reduced quality of early spontaneous motor behavior during clinical evaluation. The method uses specific pressure stimulation zones to activate innate locomotor patterns aimed at improving postural control, axial stability, and motor coordination. In this study, Vojta therapy was not assigned by the research protocol but initiated by caregivers following clinical recommendation. Therefore, exposure to Vojta method represents a naturally occurring, non-randomized behavioral intervention and is analyzed only for exploratory purposes.

06

What researchers measure

Primary outcomes

  1. Association Between the Quality of Early Spontaneous Movements and Developmental Outcomes at 18 and at 36 months

    The quality of early spontaneous movements will be evaluated using standardized observational assessment in infancy. Developmental outcomes at 18 and 36 months will be compared between infants displaying typical movement quality and those showing reduced or atypical movement quality. This analysis aims to determine whether early differences in spontaneous motor behavior are associated with variations in later developmental functioning.

    Time frame: april 2024 - july 2027

Secondary outcomes

  1. Correlation Between MOS-R and Specific Developmental Sub-Domains (Motor vs. Non-Motor)

    Assessment of the relationship between early MOS-R scores and specific sub-scales of the caregiver questionnaire at both 18 and 36 months. The analysis will distinguish between Gross/Fine Motor scores versus Communication and Social-Emotional scores. The aim is to evaluate whether early motor optimality is a stronger predictor of later motor skills compared to cognitive/language skills.

    Time frame: april 2024 - july 2027

Other outcomes

  1. Predictive Validity of MOS-R in Preterm vs. Full-Term Cohorts

    Comparison of the association strength between MOS-R and later developmental outcomes in the Preterm cohort (born \<37 weeks) versus the Full-Term cohort. This measure investigates whether the predictive value of early motor assessment differs based on gestational age at birth.

    Time frame: april 2024 - july 2027

  2. Developmental Outcomes in Infants With Atypical Early Movement Quality Who Did or Did Not Receive Early Therapy

    Among infants displaying atypical or reduced quality of early spontaneous movements, developmental outcomes at 18 and 36 months will be compared based on whether families chose to initiate early physiotherapy. Because group assignment is based on parental decision-making and not randomization, this outcome is exploratory and may be influenced by indication bias.

    Time frame: april 2024 - july 2027

07

Study locations

3 of 3 sites recruiting
  • Nemocnice Pardubického kraje, a.s.
    Pardubice, Czechia 53002, Czechia
    Recruiting
  • Lentilka - integrated kindergarden and rehabilitation center
    Pardubice, Česká Republika 530 02, Czechia
    Recruiting
  • Lentilka - integrated kindergarden and rehabilitation center
    Pardubice, Česká Republika 530 02, Czechia
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Apr 2024 (actual). Primary completion is estimated for Jan 2027, 32 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: primary completion Jul 2026 → Jan 2027 and completion Jul 2027 → Jan 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 8, 2025
First posted
Dec 22, 2025
StartActual
Apr 19, 2024
Primary completionEst.
Jan 1, 2027was Jul 2026
CompletionEst.
Jan 1, 2027was Jul 2027
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jul 28, 2026→Jan 1, 2027
Nov 5, 2026
Study completion
Jul 30, 2027→Jan 1, 2027
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Primary completion Jul 28, 2026→Jan 1, 2027
    Study completion Jul 30, 2027→Jan 1, 2027

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07296003
Lead sponsor
Masaryk University
Responsible party
Sponsor
First posted
Dec 22, 2025
Start date
Apr 19, 2024
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 1, 2027 (estimated)
Last update
Nov 5, 2026

Study contacts

Lukas Teply, Master degree
Contact
l.teply@seznam.cz
+420776845807

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion